Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Effect of vitamin E supplementation on blood pressure: a systematic review and meta-analysis

Abstract

Although emerging evidence suggests that vitamin E may contribute to blood pressure improvement, the effects of vitamin E on systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) are still controversial. The aim was to evaluate the influence of vitamin E on SBP, DBP, and MAP through meta-analysis. We identified all studies that assessed the effect of vitamin E supplementation on SBP, DBP, and MAP from PubMed/Medline, SCOPUS, and Google scholar up to March 2018. Weighted mean differences (WMD) and 95% confidence interval (CI) were expressed as effect size. Pre-specified subgroup analysis was conducted to evaluate potential sources of heterogeneity. Meta-regression analyses were performed to investigate association between blood pressure-lowering effects of vitamin E and duration of follow-up and dose of treatment. Eighteen trials, comprising 839 participants met the eligibility criteria. Results of this study showed that compared to placebo, SBP decreased significantly in vitamin E group (WMD = −3.4 mmHg, 95% CI = −6.7 to −0.11, P < 0.001), with a high heterogeneity across the studies (I2 = 94.0%, P < 0.001). Overall, there were no significant effects on DBP and MAP. This meta-analysis suggested that vitamin E supplements decreased only SBP and had no favorable effect on DBP and MAP.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet (Lond, Engl). 2005;365:217–23.

    Article  Google Scholar 

  2. Campbell NR, Lackland DT, Niebylski ML. High blood pressure: why prevention and control are urgent and important: a 2014 fact sheet from the World Hypertension League and the International Society of Hypertension. J Clin Hypertens (Greenwich, Conn). 2014;16:551–3.

    Article  Google Scholar 

  3. Fuentes R, Ilmaniemi N, Laurikainen E, Tuomilehto J, Nissinen A. Hypertension in developing economies: a review of population-based studies carried out from 1980 to 1998. J Hypertens. 2000;18:521–9.

    Article  CAS  Google Scholar 

  4. Abed Y, Abu-Haddaf S. Risk factors of hypertension at UNRWA primary health care centers in Gaza Governorates. ISRN Epidemiology. 2013;2013:9.

    Article  Google Scholar 

  5. Puzserova A, Bernatova I. Blood pressure regulation in stress: focus on nitric oxide-dependent mechanisms. Physiol Res. 2016;65:S309–S342.

    CAS  PubMed  Google Scholar 

  6. Brunner H, Cockcroft JR, Deanfield J, Donald A, Ferrannini E, Halcox J, et al. Endothelial function and dysfunction. Part II: association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens. 2005;23:233–46.

    Article  CAS  Google Scholar 

  7. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995;377:239–42.

    Article  CAS  Google Scholar 

  8. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. New Engl J Med. 2000;342:145–53.

    Article  CAS  Google Scholar 

  9. Kizhakekuttu TJ, Widlansky ME. Natural antioxidants and hypertension: promise and challenges. Cardiovasc Ther. 2010;28:e20–e32.

    Article  CAS  Google Scholar 

  10. Berry C, Brosnan MJ, Fennell J, Hamilton CA, Dominiczak AF. Oxidative stress and vascular damage in hypertension. Curr Opin Nephrol Hypertens. 2001;10:247–55.

    Article  CAS  Google Scholar 

  11. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87:840–4.

    Article  CAS  Google Scholar 

  12. Leonard SW, Traber MG. Methods for assessment of Vitamin E. In: Laboratory: Assessment of Vitamin Status. 1st edn: Elsevier; 2019. P. 79–105.

  13. Sen CK, Rink C, Khanna S. Palm oil-derived natural vitamin E alpha-tocotrienol in brain health and disease. J Am Coll Nutr. 2010;29:314s–23s.

    Article  CAS  Google Scholar 

  14. Sen CK, Rink C, Khanna S. Palm oil–derived natural vitamin E α-tocotrienol in brain health and disease. J Am Coll Nutr. 2010;29:314S–23S.

    Article  CAS  Google Scholar 

  15. Boshtam M, Rafiei M, Sadeghi K, Sarraf-Zadegan N. Vitamin E can reduce blood pressure in mild hypertensives. Int J Vitam Nutr Res. 2002;72:309–14.

    Article  CAS  Google Scholar 

  16. Mottram P, Shige H, Nestel P. Vitamin E improves arterial compliance in middle-aged men and women. Atherosclerosis. 1999;145:399–404.

    Article  CAS  Google Scholar 

  17. Aryaeian N, Shahram F, Djalali M, Eshragian MR, Djazayeri A, Sarrafnejad A. et al. Effect of conjugated linoleic acid, vitamin E and their combination on lipid profiles and blood pressure of Iranian adults with active rheumatoid arthritis. Vasc Health Risk Manag. 2008;4:1423–32.

    Article  CAS  Google Scholar 

  18. Rafraf M, Bazyun B, Sarabchian MA, Safaeiyan A, Ghaemmaghami Hezaveh SJ. Impact of vitamin E supplementation on blood pressure and Hs-CRP in type 2 diabetic patients. Health Promot Perspect. 2012;2:72–9.

    PubMed  PubMed Central  Google Scholar 

  19. Mahdy ZA, Siraj HH, Khaza’ai H, Mutalib MS, Azwar MH, Wahab MA. et al. Does palm oil vitamin E reduce the risk of pregnancy induced hypertension?. Acta Medica (Hradec Kralove)2013;56:104–9.

    Article  Google Scholar 

  20. Gazis A, White DJ, Page SR, Cockcroft JR. Effect of oral vitamin E (alpha-tocopherol) supplementation on vascular endothelial function in Type 2 diabetes mellitus. Diabet Med. 1999;16:304–11.

    Article  CAS  Google Scholar 

  21. Nang C, Piano B, Lewis A, Lycett K, Woodhouse M. Using the PICOS model to design and conduct a systematic search: a speech pathology case study. Presented at Research Week 2015. Edith Cowan University, Perth, Western Australia.

  22. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.

    Article  Google Scholar 

  23. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1–12.

    Article  CAS  Google Scholar 

  24. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.

    Article  Google Scholar 

  25. Sahebkar A. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytother Res. 2014;28:633–42.

    Article  CAS  Google Scholar 

  26. Ekhlasi G, Zarrati M, Agah S, Hosseini AF, Hosseini S, Shidfar S. et al. Effects of symbiotic and vitamin E supplementation on blood pressure, nitric oxide and inflammatory factors in non-alcoholic fatty liver disease. EXCLI J. 2017;16:278–90.

    PubMed  PubMed Central  Google Scholar 

  27. Hejazi N, Dabbaghmanesh MH, Mazloom Z, Dashtabi A. Effects of vitamin E on fasting and postprandial oxidative stress, inflammatory markers, glucose status, insulin resistance, blood pressure and pulse rate in type-2 diabetic patients: a randomized clinical trial. Galen Med J. 2015;4:67–74.

    Google Scholar 

  28. Shidfar F, Rezai KH, Hosseini SH, Haydari I. The effects of vitamin E on insulin resistance and cardiovascular diseases risk factors in metabolic syndrome. IJEM. 2009;10:445–54.

    Google Scholar 

  29. Economides PA, Khaodhiar L, Caselli A, Caballero AE, Keenan H, Bursell SE. et al. The effect of vitamin E on endothelial function of micro- and macrocirculation and left ventricular function in type 1 and type 2 diabetic patients. Diabetes. 2005;54:204–11.

    Article  CAS  Google Scholar 

  30. Jessup JV, Horne C, Yarandi H, Quindry J. The effects of endurance exercise and vitamin E on oxidative stress in the elderly. Biol Res Nurs. 2003;5:47–55.

    Article  Google Scholar 

  31. Stonehouse W, Brinkworth GD, Thompson CH, Abeywardena MY. Short term effects of palm-tocotrienol and palm-carotenes on vascular function and cardiovascular disease risk: a randomised controlled trial. Atherosclerosis. 2016;254:205–14.

    Article  CAS  Google Scholar 

  32. Ward NC, Wu JH, Clarke MW, Puddey IB, Burke V, Croft KD. et al. The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. J Hypertens. 2007;25:227–34.

    Article  CAS  Google Scholar 

  33. Barbagallo M, Dominguez LJ, Tagliamonte MR, Resnick LM, Paolisso G. Effects of vitamin e and glutathione on glucose metabolism: role of magnesium. Hypertension. 1999;34:1002–6.

    Article  CAS  Google Scholar 

  34. Palumbo G, Avanzini F, Alli C, Roncaglioni MC, Ronchi E, Cristofari M. et al. Effects of Vitamin E on clinic and ambulatory blood pressure in treated hypertensive patients. Am J Hypertens. 2000;13:564–7.

    Article  CAS  Google Scholar 

  35. Baliarsingh S, Beg ZH, Ahmad J. The therapeutic impacts of tocotrienols in type 2 diabetic patients with hyperlipidemia. Atherosclerosis. 2005;182:367–74.

    Article  CAS  Google Scholar 

  36. Patil SM, Chaudhuri D, Dhanakshirur GB. Role of alpha-tocopherol in cardiopulmonary fitness in endurance athletes, cyclists. Indian J Physiol Pharmacol. 2009;53:375–9.

    CAS  PubMed  Google Scholar 

  37. Motoyama T, Kawano H, Kugiyama K, Hirashima O, Ohgushi M, Tsunoda R, et al. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J Am Coll Cardiol. 1998;32:1672–9.

    Article  CAS  Google Scholar 

  38. Rasool AH, Yuen KH, Yusoff K, Wong AR, Rahman AR. Dose dependent elevation of plasma tocotrienol levels and its effect on arterial compliance, plasma total antioxidant status, and lipid profile in healthy humans supplemented with tocotrienol rich vitamin E. J Nutr Sci Vitaminol (Tokyo). 2006;52:473–8.

    Article  CAS  Google Scholar 

  39. IMcSorley PT, Bell PM, Young IS, Atkinson AB, Sheridan B, Fee JP. et al. Endothelial function, insulin action and cardiovascular risk factors in young healthy adult offspring of parents with Type 2 diabetes: effect of vitamin E in a randomized double-blind, controlled clinical trial. Diabet Med. 2005;22:703–10.

    Article  Google Scholar 

  40. Raghuvanshi R, Chandra M, Mishra A, Misra MK. Effect of vitamin E administration on blood pressure following reperfusion of patients with myocardial infarction. Exp Clin Cardiol. 2007;12:87–90.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. González J, Valls N, Brito R, Rodrigo R. Essential hypertension and oxidative stress: new insights. World J Cardiol. 2014;6:353.

    Article  Google Scholar 

  42. Ndisang JF, Vannacci A, Rastogi S. Oxidative stress and inflammation in obesity, diabetes, hypertension, and related cardiometabolic complications. Oxid Med Cell Longev. 2014;https://www.hindawi.com/journals/omcl/2014/506948/.

  43. Musiek ES, Yin H, Milne GL, Morrow JD. Recent advances in the biochemistry and clinical relevance of the isoprostane pathway. Lipids. 2005;40:987–94.

    Article  CAS  Google Scholar 

  44. Chen S-P, Chung Y-T, Liu T-Y, Wang Y-F, Fuh J-L, Wang S-J. Oxidative stress and increased formation of vasoconstricting F2-isoprostanes in patients with reversible cerebral vasoconstriction syndrome. Free Radic Biol Med. 2013;61:243–8.

    Article  CAS  Google Scholar 

  45. Barden A, Zilkens RR, Croft K, Mori T, Burke V, Beilin LJ, et al. A reduction in alcohol consumption is associated with reduced plasma F2-isoprostanes and urinary 20-HETE excretion in men. Free Radic Biol Med. 2007;42:1730–5.

    Article  CAS  Google Scholar 

  46. Wu D, Liu L, Meydani M, Meydani SN. Vitamin E increases production of vasodilator prostanoids in human aortic endothelial cells through opposing effects on cyclooxygenase-2 and phospholipase A2. J Nutr. 2005;135:1847–53.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shahab Alizadeh.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Emami, M.R., Safabakhsh, M., Alizadeh, S. et al. Effect of vitamin E supplementation on blood pressure: a systematic review and meta-analysis. J Hum Hypertens 33, 499–507 (2019). https://doi.org/10.1038/s41371-019-0192-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41371-019-0192-0

This article is cited by

Search

Quick links